v3.26.1
EARNINGS PER SHARE (Tables)
6 Months Ended
Jun. 27, 2026
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following table sets forth the calculation of basic and diluted earnings per share of Class A common stock:

(in millions, except number of shares and per share amounts)Three Months EndedSix Months Ended
June 27, 2026June 27, 2026
Basic earnings per share:
Numerator
Net income$139 $378 
Less: Net income attributable to noncontrolling interests79 189 
Net income attributable to Medline Inc.$60 $189 
Reallocation of net income attributed to vested incentive units(1)
Numerator for earnings per share$59 $197 
Denominator
Weighted-average number of Class A common stock outstanding856,671,262 838,299,245 
Basic earnings per share$0.07 $0.23 
Diluted earnings per share:
Numerator
Numerator for earnings per share (Basic)$59 $197 
Effect of dilutive stock compensation awards— — 
Numerator for earnings per share (Diluted)$59 $197 
Denominator
Weighted-average number of Class A common stock outstanding (Basic)856,671,262 838,299,245 
Weighted-average effect of dilutive securities:
Effect of dilutive stock compensation awards4,219,457 4,580,411 
Weighted-average number of Class A common stock outstanding (Diluted)860,890,719 842,879,656 
Diluted earnings per share$0.07 $0.23 
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table presents outstanding shares of potentially dilutive securities excluded from the calculation of diluted earnings per share because including them would have had an anti-dilutive effect, or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied at the end of the respective period:

Three Months EndedSix Months Ended
June 27, 2026June 27, 2026
Class B common stock437,356,274 437,356,274 
Incentive units39,347,705 39,347,705 
PSUs1,206,267 1,206,267 
RSUs1,083,429 — 
Total anti-dilutive securities478,993,675 477,910,246